Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 1996-07-01 (29 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: FENOUILLET (31150), Haute-Garonne
PHARMACIE LOURTAU-GUILHOT : revenue, balance sheet and financial ratios
PHARMACIE LOURTAU-GUILHOT is a French company
founded 29 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in FENOUILLET (31150),
this company of category PME
shows in 2018 a revenue of 2.4 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE LOURTAU-GUILHOT (SIREN 409269420)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
2 433 015 €
2 406 970 €
2 421 183 €
Net income
101 572 €
47 962 €
257 028 €
400 875 €
405 632 €
205 277 €
206 598 €
198 035 €
145 444 €
84 663 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
257 957 €
191 368 €
148 507 €
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
8.1%
6.0%
3.5%
Revenue and income statement
In 2025, PHARMACIE LOURTAU-GUILHOT generates positive net income of 102 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 85 k€ -> 102 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
101 572 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 27%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 70%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
27.174%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
27.168
18.959
19.716
18.681
13.92
7.314
2.88
0.067
0.056
27.174
Financial autonomy
66.133
74.25
73.622
71.667
77.657
82.801
84.205
83.609
80.058
69.888
Repayment capacity
2.593
1.506
1.174
None
None
None
None
None
None
None
Cash flow / Revenue
5.995%
7.591%
10.432%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
27.172025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Good+9 pts over 3 years
In 2025, the debt ratio of PHARMACIE LOURTAU-GUILHOT (27.17) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
69.89%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Good
In 2025, the financial autonomy of PHARMACIE LOURTAU-GUILHOT (69.9%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE LOURTAU-GUILHOT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
302 430 €
168 849 €
219 507 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
35
30
32
0
0
0
0
0
0
0
Customer payment term (days)
6
5
7
0
0
0
0
0
0
0
Supplier payment term (days)
48
27
35
0
0
0
0
0
0
0
Positioning of PHARMACIE LOURTAU-GUILHOT in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE LOURTAU-GUILHOT is estimated at
1 613 483 €
(range 1 094 917€ - 2 531 777€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1094k€1613k€2531k€
1 613 483 €Range: 1 094 917€ - 2 531 777€
NAF 5 année 2025
Valuation method used
Net Income Multiple
101 572 €
×
15.9x
=1 613 483 €
Range: 1 094 917€ - 2 531 777€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE LOURTAU-GUILHOT with other companies in the same sector:
Frequently asked questions about PHARMACIE LOURTAU-GUILHOT
What is the revenue of PHARMACIE LOURTAU-GUILHOT ?
The revenue of PHARMACIE LOURTAU-GUILHOT in 2018 is 2.4 M€.
Is PHARMACIE LOURTAU-GUILHOT profitable?
Yes, PHARMACIE LOURTAU-GUILHOT generated a net profit of 102 k€ in 2025.
Where is the headquarters of PHARMACIE LOURTAU-GUILHOT ?
The headquarters of PHARMACIE LOURTAU-GUILHOT is located in FENOUILLET (31150), in the department Haute-Garonne.
Where to find the tax return of PHARMACIE LOURTAU-GUILHOT ?
The tax return of PHARMACIE LOURTAU-GUILHOT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE LOURTAU-GUILHOT operate?
PHARMACIE LOURTAU-GUILHOT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart